Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

Similar articles for PubMed (Select 23645508)

1.

COPD patients with and without metabolic syndrome: clinical and functional differences.

Díez-Manglano J, Barquero-Romero J, Almagro P, Cabrera FJ, López García F, Montero L, Soriano JB; Working Group on COPD; Spanish Society of Internal Medicine.

Intern Emerg Med. 2014 Jun;9(4):419-25. doi: 10.1007/s11739-013-0945-7. Epub 2013 May 5.

PMID:
23645508
2.

Comorbidities and short-term prognosis in patients hospitalized for acute exacerbation of COPD: the EPOC en Servicios de medicina interna (ESMI) study.

Almagro P, Cabrera FJ, Diez J, Boixeda R, Alonso Ortiz MB, Murio C, Soriano JB; Working Group on COPD , Spanish Society of Internal Medicine.

Chest. 2012 Nov;142(5):1126-33. doi: 10.1378/chest.11-2413.

PMID:
23303399
3.

Comorbidity and gender-related differences in patients hospitalized for COPD. The ECCO study.

Almagro P, López García F, Cabrera F, Montero L, Morchón D, Díez J, Soriano J; Grupo Epoc De La Sociedad Española De Medicina Interna.

Respir Med. 2010 Feb;104(2):253-9. doi: 10.1016/j.rmed.2009.09.019. Epub 2009 Oct 30.

4.

Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study.

Zhang J, Lin XF, Bai CX.

Int J Chron Obstruct Pulmon Dis. 2014;9:57-63. doi: 10.2147/COPD.S52416. Epub 2014 Jan 8.

5.

[Prevalence and difficulties in chronic obstructive pulmonary disease diagnosis in patients suffering from severe peripheral arterial disease].

Sleszycka J, Woźniak K, Banaszek M, Wiechno W, Domagała-Kulawik J.

Pol Merkur Lekarski. 2009 Aug;27(158):92-6. Polish.

PMID:
19856871
6.

Prevalence and characteristics of three clinical phenotypes of chronic obstructive pulmonary disease (COPD).

Izquierdo-Alonso JL, Rodriguez-Gonzálezmoro JM, de Lucas-Ramos P, Unzueta I, Ribera X, Antón E, Martín A.

Respir Med. 2013 May;107(5):724-31. doi: 10.1016/j.rmed.2013.01.001. Epub 2013 Feb 16.

7.

Gender associated differences in determinants of quality of life in patients with COPD: a case series study.

de Torres JP, Casanova C, Hernández C, Abreu J, Montejo de Garcini A, Aguirre-Jaime A, Celli BR.

Health Qual Life Outcomes. 2006 Sep 28;4:72.

8.

Metabolic syndrome is associated with increased risk of acute exacerbation of COPD: a preliminary study.

Küpeli E, Ulubay G, Ulasli SS, Sahin T, Erayman Z, Gürsoy A.

Endocrine. 2010 Aug;38(1):76-82. doi: 10.1007/s12020-010-9351-3. Epub 2010 Jun 9.

PMID:
20960105
9.

[Mortality and comorbidity in hospitalized chronic obstructive pulmonary disease patients].

Rubinsztajn R, Chazan R.

Pneumonol Alergol Pol. 2011;79(5):343-6. Polish.

10.

Metabolic syndrome and carotid intima-media thickness in chronic obstructive pulmonary disease.

Ozgen Alpaydin A, Konyar Arslan I, Serter S, Sakar Coskun A, Celik P, Taneli F, Yorgancioglu A.

Multidiscip Respir Med. 2013 Sep 17;8(1):61. doi: 10.1186/2049-6958-8-61.

11.

INDACO project: a pilot study on incidence of comorbidities in COPD patients referred to pneumology units.

Fumagalli G, Fabiani F, Forte S, Napolitano M, Marinelli P, Palange P, Pentassuglia A, Carlone S, Sanguinetti CM.

Multidiscip Respir Med. 2013 Apr 3;8(1):28. doi: 10.1186/2049-6958-8-28.

12.

Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.

Keam SJ, Keating GM.

Treat Respir Med. 2004;3(4):247-68. Review.

PMID:
15350163
13.

Survival in COPD: impact of lung dysfunction and comorbidities.

Miniati M, Monti S, Pavlickova I, Bottai M.

Medicine (Baltimore). 2014 Sep;93(12):e76. doi: 10.1097/MD.0000000000000076.

PMID:
25211048
14.

Impact of comorbidities on COPD-specific health-related quality of life.

Burgel PR, Escamilla R, Perez T, Carré P, Caillaud D, Chanez P, Pinet C, Jebrak G, Brinchault G, Court-Fortune I, Paillasseur JL, Roche N; INITIATIVES BPCO Scientific Committee.

Respir Med. 2013 Feb;107(2):233-41. doi: 10.1016/j.rmed.2012.10.002. Epub 2012 Oct 23.

15.

[Comorbidities in patients hospitalized due to chronic obstructive pulmonary disease. A comparative analysis of the ECCO and ESMI studies].

Almagro P, López F, Cabrera FJ, Portillo J, Fernández-Ruiz M, Zubillaga E, Díez J, Román P, Murcia-Zaragoza J, Boixeda R, Murio C, Soriano JB; Grupos de trabajo de EPOC y Paciente Pluripatológico y Edad Avanzada de la Sociedad Española de Medicina Interna.

Rev Clin Esp. 2012 Jun;212(6):281-6. doi: 10.1016/j.rce.2012.02.014. Epub 2012 Apr 21. Spanish.

PMID:
22521437
16.

Short- and medium-term prognosis in patients hospitalized for COPD exacerbation: the CODEX index.

Almagro P, Soriano JB, Cabrera FJ, Boixeda R, Alonso-Ortiz MB, Barreiro B, Diez-Manglano J, Murio C, Heredia JL; Working Group on COPD, Spanish Society of Internal Medicine.

Chest. 2014 May;145(5):972-80.

PMID:
24077342
17.

Contemporary issues in the care of patients with chronic obstructive pulmonary disease.

Urbano FL, Pascual RM.

J Manag Care Pharm. 2005 Jun;11(5 Suppl A):S2-13; quiz S14-6. Review.

18.

[The importance of the at risk COPD patients (Stage 0) and clinical differences].

Kömüs N, Tertemiz KC, Sevinç C.

Tuberk Toraks. 2008;56(4):382-9. Turkish.

PMID:
19123073
19.

Clinical characteristics and quality of life in women with COPD: an observational study.

Raherison C, Tillie-Leblond I, Prudhomme A, Taillé C, Biron E, Nocent-Ejnaini C, Mathieu B, Ostinelli J.

BMC Womens Health. 2014 Feb 20;14(1):31. doi: 10.1186/1472-6874-14-31.

20.

Reduced level of physical activity in Japanese patients with chronic obstructive pulmonary disease.

Minakata Y, Sugino A, Kanda M, Ichikawa T, Akamatsu K, Koarai A, Hirano T, Nakanishi M, Sugiura H, Matsunaga K, Ichinose M.

Respir Investig. 2014 Jan;52(1):41-8. doi: 10.1016/j.resinv.2013.06.002. Epub 2013 Jul 18.

PMID:
24388370
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk